357 filings
Page 7 of 18
6-K
TRIL
Trillium Therapeutics Inc.
29 May 20
Trillium Therapeutics Provides Update on the Phase I
8:00am
6-K
TRIL
Trillium Therapeutics Inc.
26 May 20
Annual General and Special Meeting
7:01am
6-K
TRIL
Trillium Therapeutics Inc.
15 May 20
Consolidated Financial Statements
5:00pm
6-K
TRIL
Trillium Therapeutics Inc.
13 May 20
Current report (foreign)
7:04am
SC 13G/A
TRIL
Trillium Therapeutics Inc.
11 May 20
Trillium Therapeutics / MORGAN STANLEY ownership change
4:13pm
6-K
TRIL
Trillium Therapeutics Inc.
6 May 20
Trillium Therapeutics Announces "At-the-market" Equity Program
7:12am
UPLOAD
TRIL
Trillium Therapeutics Inc.
6 May 20
Letter from SEC
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
5 May 20
Current report (foreign)
5:21pm
424B5
TRIL
Trillium Therapeutics Inc.
5 May 20
Prospectus supplement for primary offering
5:17pm
EFFECT
TRIL
Trillium Therapeutics Inc.
5 May 20
Notice of effectiveness
12:15am
F-3/A
TRIL
Trillium Therapeutics Inc.
30 Apr 20
Shelf registration (foreign) (amended)
4:08pm
CORRESP
TRIL
Trillium Therapeutics Inc.
30 Apr 20
Correspondence with SEC
12:00am
F-3
TRIL
Trillium Therapeutics Inc.
23 Apr 20
Shelf registration (foreign)
4:48pm
6-K
TRIL
Trillium Therapeutics Inc.
23 Apr 20
Current report (foreign)
4:21pm
6-K
TRIL
Trillium Therapeutics Inc.
8 Apr 20
Trillium Therapeutics Provides Business Update In Response to the COVID-19 Pandemic
7:08am
6-K
TRIL
Trillium Therapeutics Inc.
10 Mar 20
Trillium Therapeutics Reports Annual Financial and Operating Results
7:09am
40-F
2019 FY
TRIL
Trillium Therapeutics Inc.
10 Mar 20
Annual report (Canada)
7:06am
6-K
TRIL
Trillium Therapeutics Inc.
28 Feb 20
Current report (foreign)
12:31pm
SC 13G
TRIL
Trillium Therapeutics Inc.
14 Feb 20
Beneficial ownership report
4:00pm
SC 13G/A
TRIL
Trillium Therapeutics Inc.
14 Feb 20
Beneficial ownership report (amended)
10:31am